Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Noguerido A"'
Autor:
Elena Elez, Chiara Chianese, Enrique Sanz‐García, Erica Martinelli, Alba Noguerido, Francesco Mattia Mancuso, Ginevra Caratù, Judit Matito, Julieta Grasselli, Claudia Cardone, Riziero Esposito Abate, Giulia Martini, Cristina Santos, Teresa Macarulla, Guillem Argilés, Jaume Capdevila, Ariadna Garcia, Nuria Mulet, Evaristo Maiello, Nicola Normanno, Frederick Jones, Josep Tabernero, Fortunato Ciardello, Ramon Salazar, Ana Vivancos
Publikováno v:
Molecular Oncology, Vol 13, Iss 9, Pp 1827-1835 (2019)
Despite major advances in the treatment of metastatic colorectal cancer (mCRC), the survival rate remains very poor. This study aims at exploring the prognostic value of RAS‐mutant allele fraction (MAF) in plasma in mCRC. Forty‐seven plasma sampl
Externí odkaz:
https://doaj.org/article/3ba50329631d4c038cfdd0a1c4537257
Autor:
Elena Élez, Núria Mulet-Margalef, Miriam Sanso, Fiorella Ruiz-Pace, Francesco M. Mancuso, Raquel Comas, Javier Ros, Guillem Argilés, Giulia Martini, Enrique Sanz-Garcia, Iosune Baraibar, Francesc Salvà, Alba Noguerido, Jose Luis Cuadra-Urteaga, Roberta Fasani, Ariadna Garcia, Jose Jimenez, Susana Aguilar, Stefania Landolfi, Javier Hernández-Losa, Irene Braña, Paolo Nuciforo, Rodrigo Dienstmann, Josep Tabernero, Ramon Salazar, Ana Vivancos
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 1; Pages: 118
Scientia
Scientia
Biomarkers; Colorectal cancer; Immunotherapy Biomarcadors; Càncer colorectal; Immunoteràpia Biomarcadores; Cáncer colorrectal; Inmunoterapia The search for immunotherapy biomarkers in Microsatellite Instability High/Deficient Mismatch Repair syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70bacfe4702a115d21d52cef1988afcb
https://doi.org/10.3390/ijms24010118
https://doi.org/10.3390/ijms24010118
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nuria Mulet, Guillem Argiles, Elena Elez, Alba Noguerido, Josep Tabernero, Ignacio Matos, Javier Ros
Publikováno v:
Expert Opinion on Investigational Drugs. 28:463-471
INTRODUCTION The addition of monoclonal antibody (mAb) epidermal growth factor receptor (EGFR) inhibitors to classic chemotherapy doublet backbones has improved survival of metastatic colorectal cancer (mCRC). However, the role of triple-drug chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ff07ff9034052701fac70733c079b6
https://doi.org/10.1080/13543784.2019.1599860
https://doi.org/10.1080/13543784.2019.1599860
Autor:
Ramon Salazar, Chiara Chianese, Evaristo Maiello, Alba Noguerido, Josep Tabernero, Ana Vivancos, Erica Martinelli, Judit Matito, Guillem Argiles, Cristina Santos, Giulia Martini, Ginevra Caratu, Jaume Capdevila, Ariadna Garcia, Francesco M. Mancuso, Julieta Grasselli, Nuria Mulet, Nicola Normanno, Fortunato Ciardello, Enrique Sanz-Garcia, Claudia Cardone, Elena Elez, Frederick S. Jones, Riziero Esposito Abate, Teresa Macarulla
Publikováno v:
Molecular Oncology
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Molecular Oncology, Vol 13, Iss 9, Pp 1827-1835 (2019)
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Molecular Oncology, Vol 13, Iss 9, Pp 1827-1835 (2019)
Metastatic colorectal cancer; RAS analysis; Prognostic biomarker Cáncer colorrectal en metástasis; Análisis RAS; Biomarcador como pronóstico Càncer colorectal en metàstasi; Anàlisi RAS; Biomarcador com a pronòstic Despite major advances in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24d52ad848ac135b17820e68bac00528
https://pubmed.ncbi.nlm.nih.gov/31322322
https://pubmed.ncbi.nlm.nih.gov/31322322
Autor:
Núria Mulet-Margalef, Ignacio Matos, Guillem Argiles, Javier Ros, Alba Noguerido, Josep Tabernero, Elena Elez
Publikováno v:
Expert Opinion on Drug Safety. 17:945-951
Ramucirumab, a human monoclonal antibody against vascular endothelial growth factor receptor 2 (VEGFR-2), is an antiangiogenic therapy that has been approved in combination with FOLFIRI in second-line treatment of metastatic colorectal cancer (mCRC),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e9aae0775269d20eaafc532af76a69
https://doi.org/10.1080/14740338.2018.1506762
https://doi.org/10.1080/14740338.2018.1506762
Autor:
Maria Elena Elez, G Martini, Ignacio Matos, Nuria Mulet, Alba Noguerido, Josep Tabernero, Guillem Argiles
Introduction: Despite major progress in treating advanced colorectal cancer (CRC), prognosis in this population after progression on standard treatment remains dismal and the development of new drugs represents an unmet need. Historically, fluoropyri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::161feb033fed560ddaea99ff4f57545b
http://hdl.handle.net/11591/462646
http://hdl.handle.net/11591/462646
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stefania Landolfi, Ariadna Garcia, Alba Noguerido, Elena Elez, Ignacio Matos, Ana Vivancos, Giulia Martini, Jaume Capdevila, Paolo Nuciforo, Guillem Argiles, Nuria Mulet, Rodrigo Dienstmann, Javier Hernández-Losa, Raquel Comas, Juan Francisco Grau Bejar, Teresa Macarulla Mercade, Guillermo Villacampa, Josep Tabernero
Publikováno v:
Journal of Clinical Oncology. 36:3551-3551
3551Background: Pts with MSS all-RAS and BRAFV600E wild-type met CRC are more likely to respond to anti-EGFR drugs, irrespective of treatment (tx) line, particularly if left-sided primaries (prim)....
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c8f12b00d37812e41c9248fe725f7e6
https://doi.org/10.1200/jco.2018.36.15_suppl.3551
https://doi.org/10.1200/jco.2018.36.15_suppl.3551